Thursday, July 13

11:00-12:15 pm

Check-In & Registration

12:15-1:20 pm

Buffet Lunch

12:20 – 1:20 pm

Industry Supported Lecture
Presented by Novartis Pharmaceuticals
*not eligible for CME Credit

1:20-1:40 pm

Break and Exhibits

1:40-1:45 pm

Introduction and Program Overview
Kirkwood F. Adams, Jr., MD

Session I: Current Approaches to the Management of Heart Failure
Moderator: Kirkwood F. Adams, Jr., MD

1:45-2:10 pm

“Old School” But Still Essential Drug Therapies for Heart Failure
Stephanie H. Dunlap, DO

2:10-3:05 pm

Optimizing Polypharmacy – Latest Strategies to Resolve GDMT Treatment Gaps in CHF
Moderator: Kirkwood F. Adams, Jr, MD
Nancy M. Albert, PhD, RN and Stephen Green, MD
Panelists: Javed Butler, MD, MPH, MBA, Marvin Konstam, MD, and Alan B. Miller, MD

3:05-3:20 pm

Break & Exhibits

3:20-3:45 pm

Clinical Challenges: Therapeutic Concepts in Heart Failure with Preserved EF
Marvin A. Konstam, MD

3:45-4:10 pm

Latest Update on Pharmacological Agents for HFpEF – Focus on ARNI Therapy
Robert J. Mentz, MD

4:10-4:45 pm

Optimizing Polypharmacy in HFpEF: Clinical Phenotypes and Pathophysiology
Moderator: Robert J. Mentz, MD
Panelists: Javed Butler, MD and Marvin A. Konstam, MD

4:45-5:30 pm

Making Polypharmacy Work in the Clinic – Case Vignettes with Discussion
Case Presenters: Douglas D. Schocken, MD and Paul J. Hauptman, MD
Case Discussants: Stephanie H. Dunlap, DO, Robert L. Page II, PharmD, Sara Paul, DNP, and Nancy M. Albert, PhD, RN

Friday, July 14

7:30-8:00 am

Breakfast, Check-In & Exhibits

Session II: Electrophysiological Approaches to Heart Failure
Moderator: Alan B. Miller, MD

8:00-8:25 am

Electrophysiologist’s Perspective: How Can Implantable Cardiac Rhythm Management Devices Help My Heart Failure Patients?
Anil K. Gehi, MD

8:25-8:40 am

EP Panel Discussion
Discussants:  Alan B. Miller, MD, Anil K. Gehi, MD, and Matthew Baker, MD

Session III: Latest on Surgical and Device Strategies for Advanced Heart Failure
Moderator: Mirnela Byku MD, PhD, MBA, MHS 

8:40-9:05 am

Ventricular Assist Devices: Latest Strategies for Optimal Clinical Application
Mirnela Byku MD, PhD, MBA, MHS 

9:05-9:30 am

Mitral Regurgitation: Causes, Natural History, Classic and Novel Interventions
JoAnn Lindenfeld, MD

9:30-9:45 am

Break & Exhibits

9:45 -10:10 am

Real World Insights on Cardiac Assist Devices and Transplantation
James B. Young, MD

10:10-10:50 am

Surgical Approaches to Advanced Heart Failure: Patient Selection and Timing
Moderator: Mirnela Byku MD, PhD, MBA, MHS 
Case Presenter: William Mostertz, MD
Panelists: James B. Young, MD, Christopher V. Chien, MD, JoAnn Lindenfeld, MD, and William T. Abraham, MD

10:50-11:45 am

Featured Panel Discussion:  Advanced Heart Failure: Latest on Clinical Application of Mechanical Circulatory Support and Left Ventricular Assist Device Therapy
Moderator: Mirnela Byku MD, PhD, MBA, MHS 
Speaker: James C. Fang, MD
Commentary: William T. Abraham, MD, Mustafa M. Ahmed, MD, and David Lanfear, MD

Hot Topic Update on Novel and Investigational Devices for Heart Failure

11:45-12:20 pm

Expert Panel Discussion: Novel and Investigational Devices for Monitoring and Treatment of CHF
Moderator: Alan B. Miller, MD
Speakers: William T. Abraham, MD and Marvin A. Konstam, MD
Panel Discussion: JoAnn Lindenfeld, MD and Christopher V. Chien, MD

Satellite Breakout Luncheon Session

12:30-1:30 pm

Lunch and Featured Panel Discussion: TBD
Speaker: TBD
Panelists: TBD

1:30-2:30 pm

Concurrent Workshops

Nursing Challenges in Caring for the Chronic Heart Failure Patient
Jana M. Glotzer, MSN, ACNP, Sarah Waters, ANP-BC, Carrie Neal, RN, BSN, Tammy Long, AGNP, MSN, and Emily Baker, MSN, AGNP-C

Optimizing Patient Selection for EP Device and Intervention Therapy
Anil K. Gehi, MD and Matthew Baker, MD

Clinical Application of Biomarkers and Omics in Day to Day Heart Failure Patient Care
Kirkwood F. Adams, Jr., MD, Ileana L. Piña, MD, MPH, and David E. Lanfear, MD

Case-Based Interactive Discussion: How to Do an Effective Heart Failure History and Physical
Douglas D. Schocken, MD

Cardio-Oncology: Clinical Case Discussions
Jo Ellen Rodgers, PharmD and Brian C. Jensen, MD

Saturday, July 15

7:15-8:30 am

Breakfast, Check-In & Exhibits

7:30 – 8:30 am

Industry Supported Lecture
*not eligible for CME Credit

8:30 – 9:00 am

Break & Exhibits

Session IV: Future Directions in Heart Failure Therapy: Biomarkers, Cardiomyopathy, and Late Breaking Trials
Moderator: Kirkwood F. Adams, Jr., MD

9:00-9:20 am

Early Recognition and Definition of Heart Failure: Role of Biomarkers and Omics
David E. Lanfear, MD and Peter P. Liu, MD

9:20-9:30 am

Q & A/Panel Discussion

9:30-10:00 am

Advances in Diagnosis and Treatment of Cardiac Amyloid: Key Role of Novel Drug Therapy
Mathew S. Maurer, MD

10:00-10:10 am

Clinical Discussion of Nuances in the Management of Cardiac Amyloid
Mathew S. Maurer, MD and Alan B. Miller, MD

10:10-10:35 am

Myosin Modulation: Mavacamten in Obstructive Hypertrophic Cardiomyopathy
Anjali Owens, MD

10:35-10:50 am

Break & Exhibits

10:50-11:15 am

Guanylate Cyclase Stimulation-Vericiguat: Insights Concerning Clinical Application
Stephen Greene, MD

11:15-11:40 am

Myosin Modulation: Update on Omecamtiv Mecarbil in HFrEF: Latest Galactic-HF Results
David E. Lanfear, MD

11:40-12:05 pm

Latest Approaches with SGLT2 Inhibitors to Improve CV Outcomes in HFrEF and HFpEF
Javed Butler, MD, MPH

12:05-12:30 pm

Update on Novel Therapeutic Approaches to Heart Failure
Kirkwood F. Adams, MD

12:40-1:30 pm

Breakout Luncheon – Featured Panel

Expert Panel Discussion:  Potential Opportunities and Challenges for Novel Therapies as Components of the Polypharmacy of Heart Failure: Latest Clinical Perspectives
Moderator: Kirkwood F. Adams, Jr., MD
Speakers: Clyde W. Yancy, MD, MSc and Larry Allen, MD
Panelists: Ileana L. Piña, MD, MPH, Robert J. Mentz, MD, Javed Butler, MD, MPH
, and Stephen Greene, MD

1:30-2:30 pm

Concurrent Workshops

Pharmacotherapeutic Challenges in Treating the Heart Failure Patient
Robert L. Page II, PharmD, Barry E. Bleske, PharmD, and Erika Schoenborn, PharmD

Advanced and Refractory HF: Individualizing LVAD and Hemodynamic Monitoring Strategies
Robert T. Cole, MD, Sudha Jaganathan, MD, Lauren B. Cooper, MD, Evan Hiner, MD, and Megan Andrews, MSN, APRN, ANP-C

Unusual Cardiomyopathies: Approaches to Evaluation and Management
Mirnela Byku, MD, PhD, MBA, Mathew S. Maurer, MD, Uri Elkayam, MD, and Kirkwood F. Adams, Jr., MD

Optimizing Therapy in HF Patients with Sleep Disordered Breathing
William G. Cotts, MD

Optimizing Device Therapy for HFrEF: Cardiac Contractility Modulation Therapies for Heart Failure
Faisal F. Syed, BSc, MBChB

Sunday, July 16

7:30-8:00 am

Continental Breakfast, Check-In & Exhibits

Session V: Clinical Science to Clinical Care – Making it Happen in the CHF Clinic
Moderator: Kirkwood F. Adams, Jr., MD

8:00-8:35 am

Optimizing Care in Heart Failure – Process Matters
Ileana L. Piña, MD, MPH

8:35-9:25 am

The Team Approach to Heart Failure Patient Management
Moderator: Ileana L. Piña, MD, MPH
Panel Discussion: Tammy Long, AGNP, MSN, Jana M. Glotzer, MSN, ACNP, and Katherine Di Palo, PharmD

9:25-9:50 am

Advancing the Cardiovascular Care of the Oncology Patient
Jo Ellen Rodgers, PharmD and Brian C. Jensen, MD

9:50-10:20 am

Pulmonary Arterial Hypertension: Latest Concepts in Evaluation and Treatment
Lisa J. Rose-Jones, MD

10:20-10:50 am

Atrial Fibrillation: Consequences and Therapeutic Implications in CHF
Anil K. Gehi, MD

10:50-11:10 am

Current Clinical Approaches to Important Co-morbidities in Heart Failure
Moderator: Kirkwood F. Adams, Jr., MD
Panel Discussion:
Lisa J. Rose-Jones, MD, Brian C. Jensen, MD, Anil K. Gehi, MD, and Jo Ellen Rodgers, PharmD

11:10-12:00 pm

Heart Failure Management Forum: Strategies to Optimize Decision Making in CHF Care
Moderators: Ileana L. Piña, MD, MPH and Kirkwood F. Adams, Jr., MD

12:00 pm